Home    Back

Ketoflo    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
248Glucose transporter type 1 deficiency1

248. Glucose transporter type 1 deficiency    [ 30 clinical trials,   9 drugs,   (DrugBank: 1 drug),   0 drug target gene,   0 drug target pathway]
Searched query = "Glucose transporter type 1 deficiency", "GLUT1 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 30 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04399954
(ClinicalTrials.gov)		February 24, 202018/5/2020Evaluation of KetofloA Study to Evaluate the Acceptability of Ketoflo, a Food for Special Medical Purposes (FSMP) for Use in the Dietary Management of Epilepsy or Neurometabolic Conditions Requiring a Ketogenic Diet (KD)Epilepsy Intractable;Glucose Transporter Type 1 Deficiency Syndrome;Ketogenic DietingDietary Supplement: KetofloVitaflo International, LtdNULLRecruiting3 Years18 YearsAll15N/AUnited Kingdom